EXHIBIT 12. STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS FROM CONTINUING OPERATIONS TO FIXED CHARGES (Unaudited) Eli Lilly and Company and Subsidiaries (Dollars in Millions) Nine Months Ended Years Ended December 31, September 30, ------------------------------------------------------ 1997 1996 1995 1994 1993 1992 ---- ---- ---- ---- ---- ---- Consolidated Pretax Income (loss) from Continuing Operations before Accounting Changes.......... $ (99.8) $2,031.3 $1,765.6 $1,698.6 $ 662.8 $1,193.5 Interest from Continuing Operations.................. 199.0 324.9 324.6 129.2 96.1 108.4 Less Interest Capitalized during the Period from Continuing Operations.................. (18.6) (36.1) (38.3) (25.4) (25.5) (35.2) ------- -------- -------- -------- ------ -------- Earnings...................... $ 80.6 $2,320.1 $2,051.9 $1,802.4 $733.4 $1,266.7 ======= ======== ======== ======== ====== ======== Fixed Charges(1).............. $ 201.7 $ 329.6 $ 324.6 $ 129.2 $ 96.1 $ 108.4 ======= ======== ======== ======== ====== ======== Ratio of Earnings to Fixed Charges.............. 0.4(2) 7.0 6.3 14.0 7.6 11.7 ======= ======== ======== ======== ====== ======== (1) Fixed charges include interest from continuing operations for all years presented and beginning in 1996, preferred stock dividends. (2) Included in the 1997 earnings is a non-cash charge of $2,443 million due to an asset impairment. See notes to consolidated condensed financial statements. If the asset impairment charge had not occurred, the ratio of earnings to fixed charges would have been 12.5.